In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Focus on update on the role of SGLT2i for the treatment of patients with heart failure

ESC Webinar Series - Diabetes. Organised by the Heart Failure Association (HFA)

18/12/2020 18:00 18/12/2020 19:00 Europe/Paris Focus on update on the role of SGLT2i for the treatment of patients with heart failure

Access event page

Heart Failure Association of the ESC DD/MM/YYYY
Diabetes and the Heart
Pathophysiology and Mechanisms
Diagnostic Methods
Heart Failure Association
Diagnostic Methods
Pathophysiology and Mechanisms
Heart Failure


Join Prof. Andrew Coats, Prof. Giuseppe Rosano and Prof. Michel Komajda.

Free for everyone.

Focus on

Learning objectives

  • Get updated on the management of heart failure, both acute and chronic, according to the newly released guidelines of the ESC/HFA
  • For clinicians, get updated on the effect of SGLT2i on the prevention and treatment of diabetic and non-diabetic patients with heart failure 
  • Discuss the role of SGLT2i in the prevention of heart failure
  • Discuss the place in therapy for SGLT2i in patients with heart failure
  • Discuss potential differences between molecules of the same class

Register now

Free for everyone.



Andrew-Coats-2019.jpgProfessor Andrew Coats, FESC, FHFA
University of Warwick
Coventry, UK

Giuseppe M.C. Rosano.jpgProfessor Giuseppe Rosano, FESC, FHFA
St. George's Hospital Medical School
London, UK


Michel Komajda_photo.pngProfessor Michel Komajda, FESC
Saint Joseph Hospital
Paris, France


Session information

ESC Webinar Series - Diabetes
This ESC Webinar Series was designed to provide the audience with a comprehensive view of what’s new in diabetes management that will be readily applicable in everyday clinical practice.

The series will consist of four webinars addressing different topic angles. Discover the series.

Past webinars:

  Focus on management of diabetes and pre-diabetes with cardiovascular disease

  Focus on SGLT2 inhibitors – new data and guidelines change practice

Focus on managing diabetic patient with ichaemic heart disease 
(Due to COVID-19 this webinar has been cancelled)

  Focus on diabetes – a cardiac disease? From risk management to treatment

Upcoming webinars:

  Focus on targeting the cardio-renal-metabolic link

  Focus on the evidence for SGLT2i in the prevention and treatment of heart failure. SGLT2i – A new class of drugs for the treatment of heart failure

  Focus on measuring how patients feel and function in heart failure: a new era in patient empowerment

This webinar is designed for all practicing cardiologists working in the field of diabetes, pre-diabetes and cardiovascular diseases, prevention, and cardiovascular nursing, and those wishing to update their scientific knowledge on the topic.

During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.

An application has been made to the EACCME® for CME accreditation of this event.

Technical settings

The webinar is accessible on PCs and tablets. The use of a smartphone is not recommended.

To answer the MCQs during the live event, you must allow pop-up windows on your device.

A high-speed Internet connection is required (minimum 2 Mbps).